Clinical Trial Update: Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease [NA]

View source ↗

Summary

A terminated clinical trial evaluating the antidyskinetic effects of amantadine and topiramate in Parkinson's disease; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Topiramate (Topiramate)
• amantadine (amantadine)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Parkinson's Disease | NA | Status: TERMINATED | Results posted: 2017-05-11